Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth

[1]  A. Więcek,et al.  C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  Eric C. Holland,et al.  The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas , 2016, Science.

[3]  J. Massagué,et al.  Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer , 2016, Nature.

[4]  Elisa de Stanchina,et al.  Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT , 2016, Cell.

[5]  James E. Verdone,et al.  Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters , 2016, Proceedings of the National Academy of Sciences.

[6]  J. Massagué,et al.  Metastatic colonization by circulating tumour cells , 2016, Nature.

[7]  P. Steeg,et al.  Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism , 2015, Oncogene.

[8]  P. Hofman,et al.  [Standard of care of carcinomas on cancer of unknown primary site in 2016]. , 2016, Bulletin du cancer.

[9]  A. Więcek,et al.  C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  Stephen T. C. Wong,et al.  EMT is not required for lung metastasis but contributes to chemoresistance , 2015, Nature.

[11]  V. LeBleu,et al.  EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.

[12]  A. Shukla,et al.  Exosomes: Potential in Cancer Diagnosis and Therapy , 2015, Medicines.

[13]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[14]  J. Chen,et al.  Matrix metalloproteinase 13‐containing exosomes promote nasopharyngeal carcinoma metastasis , 2015, Cancer science.

[15]  J. Pollard,et al.  Therapeutic potential of chemokine signal inhibition for metastatic breast cancer , 2015, Pharmacological research.

[16]  B. Stanger,et al.  Pancreatic Cancer Metastases Harbor Evidence of Polyclonality. , 2015, Cancer discovery.

[17]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[18]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[19]  Timothy J Keyes,et al.  Structural and functional features of central nervous system lymphatics , 2015, Nature.

[20]  Jacco van Rheenen,et al.  In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior , 2015, Cell.

[21]  Alissa M. Weaver,et al.  Directional cell movement through tissues is controlled by exosome secretion , 2015, Nature Communications.

[22]  R. Pulido.  PTEN: a yin-yang master regulator protein in health and disease. , 2015, Methods.

[23]  R. Jain,et al.  Using tumour phylogenetics to identify the roots of metastasis in humans , 2015, Nature Reviews Clinical Oncology.

[24]  P. Altevogt,et al.  Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment , 2015, Oncoimmunology.

[25]  S. Raimondo,et al.  Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism , 2015, Cell Communication and Signaling.

[26]  L. Cantley,et al.  Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain. , 2015, Cancer research.

[27]  B. Knebelmann,et al.  A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients. , 2015, Journal of proteome research.

[28]  M. Zöller,et al.  The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding , 2014, Oncotarget.

[29]  R. Deberardinis,et al.  Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases , 2014, Cell.

[30]  K. Mertz,et al.  Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis , 2014, Nature.

[31]  J. Joyce,et al.  Pericellular proteolysis in cancer , 2014, Genes & development.

[32]  T. Ørntoft,et al.  Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. , 2014, Cancer research.

[33]  C. Théry,et al.  Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.

[34]  D. Lu,et al.  miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. , 2014, The American journal of pathology.

[35]  Yuxin Yin,et al.  PTEN interacts with histone H1 and controls chromatin condensation. , 2014, Cell reports.

[36]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[37]  Meg Duroux,et al.  A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.

[38]  Clotilde Théry,et al.  Biogenesis and secretion of exosomes. , 2014, Current opinion in cell biology.

[39]  Umar Mahmood,et al.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. , 2014, Cancer cell.

[40]  J. Downing,et al.  PTEN action in leukemia dictated by the tissue microenvironment , 2014, Nature.

[41]  E. Bandrés,et al.  miRNA cargo within exosome‐like vesicle transfer influences metastatic bone colonization , 2014, Molecular oncology.

[42]  Weiying Zhou,et al.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. , 2014, Cancer cell.

[43]  Olivier Elemento,et al.  Double-stranded DNA in exosomes: a novel biomarker in cancer detection , 2014, Cell Research.

[44]  S. Kondo,et al.  Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes , 2014, Oncogene.

[45]  Baojun Zhang,et al.  miR-17-92 Cluster Targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to Promote TH17-mediated Inflammation* , 2014, The Journal of Biological Chemistry.

[46]  Tingting Gu,et al.  PTEN C-terminal deletion causes genomic instability and tumor development. , 2014, Cell reports.

[47]  H. Ishitobi,et al.  Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. , 2014, Biochemical and biophysical research communications.

[48]  T. Ørntoft,et al.  Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors , 2014, Proteomics.

[49]  M. Kris,et al.  Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis , 2014, Cell.

[50]  Jian Song,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[51]  N. Vaidehi,et al.  Human breast cancer metastases to the brain display GABAergic properties in the neural niche , 2014, Proceedings of the National Academy of Sciences.

[52]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[53]  J. Massagué,et al.  Review Origins of Metastatic Traits , 2022 .

[54]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[55]  Christina S. Leslie,et al.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression , 2013, Nature Medicine.

[56]  K. Aldape,et al.  SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases. , 2013, Cancer research.

[57]  S. Emr,et al.  Molecular mechanisms of the membrane sculpting ESCRT pathway. , 2013, Cold Spring Harbor perspectives in biology.

[58]  J. Foekens,et al.  Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma , 2013, Cell.

[59]  Tomokazu Yoshizaki,et al.  Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. , 2013, Cancer letters.

[60]  Robert S. Kerbel,et al.  Differential Post-Surgical Metastasis and Survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγnull Mice with Parental and Subline Variants of Human Breast Cancer: Implications for Host Defense Mechanisms Regulating Metastasis , 2013, PloS one.

[61]  Jennifer S. Yu,et al.  Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress , 2013, Science.

[62]  V. Boussiotis,et al.  PD-1 Increases PTEN Phosphatase Activity While Decreasing PTEN Protein Stability by Inhibiting Casein Kinase 2 , 2013, Molecular and Cellular Biology.

[63]  S. Steinberg,et al.  Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells. , 2013, The American journal of pathology.

[64]  Robert M Hoffman,et al.  Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models. , 2013, Advanced drug delivery reviews.

[65]  B. Parvin,et al.  Breast fibroblasts modulate early dissemination, tumorigenesis, and metastasis through alteration of extracellular matrix characteristics. , 2013, Neoplasia.

[66]  Y. Mo,et al.  Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain , 2013, EMBO molecular medicine.

[67]  F. Ginhoux,et al.  Origin and differentiation of microglia , 2013, Front. Cell. Neurosci..

[68]  Graça Raposo,et al.  Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.

[69]  A. Viale,et al.  Epigenetic expansion of VHL-HIF signal output drives multi-organ metastasis in renal cancer , 2012, Nature Medicine.

[70]  Shuji Ogino,et al.  Restriction of intestinal stem cell expansion and the regenerative response by YAP , 2012, Nature.

[71]  A. Rajput,et al.  Restoration of PTEN activity decreases metastases in an orthotopic model of colon cancer. , 2010, The Journal of surgical research.

[72]  Alfonso Bellacosa,et al.  A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival , 2013 .

[73]  S. Ohdo,et al.  IL-6 Receptor Is a Possible Target against Growth of Metastasized Lung Tumor Cells in the Brain , 2012, International journal of molecular sciences.

[74]  J. Wrana,et al.  Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration , 2012, Cell.

[75]  A. Cashikar,et al.  Multivesicular body morphogenesis. , 2012, Annual review of cell and developmental biology.

[76]  L. Parada,et al.  PTEN signaling in autism spectrum disorders , 2012, Current Opinion in Neurobiology.

[77]  F. Reyal,et al.  Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. , 2012, Cancer research.

[78]  Peijing Zhang,et al.  LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker , 2012, Nature Medicine.

[79]  L. Poliseno.  Pseudogenes: Newly Discovered Players in Human Cancer , 2012, Science Signaling.

[80]  M. Zöller,et al.  Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. , 2012, The international journal of biochemistry & cell biology.

[81]  A. Brivanlou,et al.  The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites , 2012, Cell.

[82]  Veronica Huber,et al.  Recent advances on the role of tumor exosomes in immunosuppression and disease progression. , 2012, Seminars in cancer biology.

[83]  Lucy Pigati,et al.  MicroRNAs are exported from malignant cells in customized particles , 2012, Nucleic acids research.

[84]  Ylva Ivarsson,et al.  Syndecan–syntenin–ALIX regulates the biogenesis of exosomes , 2012, Nature Cell Biology.

[85]  Jian Zhang,et al.  SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane , 2012, Nature Communications.

[86]  B. Sharrack,et al.  PTEN: A molecular target for neurodegenerative disorders , 2012 .

[87]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[88]  Z. Dong,et al.  Claudin-2 Promotes Breast Cancer Liver Metastasis by Facilitating Tumor Cell Interactions with Hepatocytes , 2012, Molecular and Cellular Biology.

[89]  P. Pandolfi,et al.  The functions and regulation of the PTEN tumour suppressor , 2012, Nature Reviews Molecular Cell Biology.

[90]  C. Frühbeis,et al.  Emerging Roles of Exosomes in Neuron–Glia Communication , 2012, Front. Physio..

[91]  W. Grizzle,et al.  Exosomes and immune surveillance of neoplastic lesions: a review , 2012, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[92]  Xiaoqun Zhang,et al.  Functional analysis of the protein phosphatase activity of PTEN , 2012, The Biochemical journal.

[93]  Yili Yang,et al.  Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients , 2012, Journal of cellular and molecular medicine.

[94]  Carlo C. Maley,et al.  Clonal evolution in cancer , 2012, Nature.

[95]  Hong Peng,et al.  Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.

[96]  C. Théry,et al.  Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation , 2012, Journal of extracellular vesicles.

[97]  K. Aldape,et al.  PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma , 2011, Oncogene.

[98]  G. Sauter,et al.  Relevance of PTEN loss in brain metastasis formation in breast cancer patients , 2012, Breast Cancer Research.

[99]  J. Massagué,et al.  VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. , 2011, Cancer cell.

[100]  M. Watabe,et al.  Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone , 2011, The Journal of experimental medicine.

[101]  Clotilde Théry,et al.  Exosome Secretion: Molecular Mechanisms and Roles in Immune Responses , 2011, Traffic.

[102]  T. Galli,et al.  Vesicular traffic in cell navigation , 2011, The FEBS journal.

[103]  Arsen O. Batagov,et al.  Identification of nucleotide patterns enriched in secreted RNAs as putative cis-acting elements targeting them to exosome nano-vesicles , 2011, BMC Genomics.

[104]  Stephanie Alexander,et al.  Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.

[105]  J. Massagué,et al.  Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. , 2011, Cancer cell.

[106]  H. Woo,et al.  Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis , 2011, Proceedings of the National Academy of Sciences.

[107]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[108]  Gerald C. Chu,et al.  PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network. , 2011, Cancer discovery.

[109]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[110]  T. Guise,et al.  Cancer to bone: a fatal attraction , 2011, Nature Reviews Cancer.

[111]  J. Sarkaria,et al.  WWP2 is an E3 ubiquitin ligase for PTEN , 2011, Nature Cell Biology.

[112]  K. Camphausen,et al.  Brain metastases as preventive and therapeutic targets , 2011, Nature Reviews Cancer.

[113]  Yuxin Yin,et al.  CREB is a novel nuclear target of PTEN phosphatase. , 2011, Cancer research.

[114]  G. Mills,et al.  PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer , 2011, Molecular Cancer Therapeutics.

[115]  Fátima Sánchez-Cabo,et al.  Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells , 2011, Nature communications.

[116]  Hua Guo,et al.  Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways , 2011, Nature Medicine.

[117]  P. Dennis,et al.  PTEN loss in the continuum of common cancers, rare syndromes and mouse models , 2011, Nature Reviews Cancer.

[118]  B. Maček,et al.  SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis , 2011, Nature.

[119]  J. Borrell,et al.  An easy and fast way to obtain a high number of glial cells from rat cerebral tissue: A beginners approach. , 2011 .

[120]  Pier Paolo Pandolfi,et al.  Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner , 2011, Cell.

[121]  K. Vickers,et al.  MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.

[122]  G. Mills,et al.  Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. , 2010, Neoplasia.

[123]  Sascha Keller,et al.  Interaction and uptake of exosomes by ovarian cancer cells , 2011, BMC Cancer.

[124]  I. Fidler,et al.  Nitric oxide-mediated tumoricidal activity of murine microglial cells. , 2010, Translational oncology.

[125]  G. Kenter,et al.  Microparticles and exosomes in gynecologic neoplasias. , 2010, Seminars in thrombosis and hemostasis.

[126]  R. Ransohoff,et al.  Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice , 2010, PloS one.

[127]  T. Seike,et al.  Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis , 2010, Clinical & Experimental Metastasis.

[128]  A. Harris,et al.  New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. , 2010, Blood.

[129]  I. Bechmann,et al.  Microglia promote colonization of brain tissue by breast cancer cells in a Wnt‐dependent way , 2010, Glia.

[130]  Lin He,et al.  mir-17-92, a cluster of miRNAs in the midst of the cancer network. , 2010, The international journal of biochemistry & cell biology.

[131]  M. Prinz,et al.  Tickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS , 2010, Journal of Neuroimmunology.

[132]  P. Pandolfi,et al.  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010, Nature.

[133]  W. Möbius,et al.  Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A–C , 2010, The Journal of cell biology.

[134]  J. Gray,et al.  Cancer: Genomics of metastasis , 2010, Nature.

[135]  M. Loda,et al.  Identification of the miR-106b~25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation , 2010, Science Signaling.

[136]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[137]  H. Parkinson,et al.  A global map of human gene expression , 2010, Nature Biotechnology.

[138]  M. D. Chamberlain,et al.  Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase , 2010, Proceedings of the National Academy of Sciences.

[139]  K. Preissner,et al.  Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. , 2010, Cancer research.

[140]  Jochen Herms,et al.  Real-time imaging reveals the single steps of brain metastasis formation , 2010, Nature Medicine.

[141]  Miguel C. Seabra,et al.  Rab27a and Rab27b control different steps of the exosome secretion pathway , 2010, Nature Cell Biology.

[142]  Doron Betel,et al.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. , 2009, Genes & development.

[143]  S. Lowe,et al.  miR-19 is a key oncogenic component of mir-17-92. , 2009, Genes & development.

[144]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[145]  M. B. Mestre,et al.  TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways. , 2009, Biochimica et biophysica acta.

[146]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[147]  T. Nishiyama,et al.  Incorporation of Tenascin-C into the Extracellular Matrix by Periostin Underlies an Extracellular Meshwork Architecture* , 2009, The Journal of Biological Chemistry.

[148]  M. Hung,et al.  14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. , 2009, Cancer cell.

[149]  G. Grau,et al.  Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells , 2009, Leukemia.

[150]  Ruth J. Muschel,et al.  A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth , 2009, PloS one.

[151]  N. Sibson,et al.  The Vascular Basement Membrane as “Soil” in Brain Metastasis , 2009, PloS one.

[152]  Genevieve DeMaria,et al.  Characterization of exosome‐like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[153]  Reuven Agami,et al.  The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. , 2009, Genes & development.

[154]  V. Leblanc,et al.  X-linked Inhibitor of Apoptosis Protein (XIAP) Regulates PTEN Ubiquitination, Content, and Compartmentalization* , 2009, The Journal of Biological Chemistry.

[155]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[156]  Yiling Lu,et al.  Rak functions as a tumor suppressor by regulating PTEN protein stability and function. , 2009, Cancer cell.

[157]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[158]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[159]  S. Baker,et al.  PTEN and the PI3-kinase pathway in cancer. , 2009, Annual review of pathology.

[160]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[161]  J. Barata,et al.  PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. , 2008, The Journal of clinical investigation.

[162]  I. Batty,et al.  Understanding PTEN regulation: PIP2, polarity and protein stability , 2008, Oncogene.

[163]  S. Steinberg,et al.  Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. , 2008, Journal of the National Cancer Institute.

[164]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[165]  Q. Zeng,et al.  A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. , 2008, Cancer research.

[166]  Dong Wei,et al.  Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined With GM-CSF for Colorectal Cancer , 2008, Molecular Therapy.

[167]  W. Sellers,et al.  PTEN Nuclear Localization Is Regulated by Oxidative Stress and Mediates p53-Dependent Tumor Suppression , 2008, Molecular and Cellular Biology.

[168]  Rudolf Jaenisch,et al.  Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters , 2008, Cell.

[169]  G. Parmiani,et al.  Tumour-released exosomes and their implications in cancer immunity , 2008, Cell Death and Differentiation.

[170]  Lloyd J. Old,et al.  Adaptive immunity maintains occult cancer in an equilibrium state , 2007, Nature.

[171]  B. Eickholt,et al.  Function of PTEN during the Formation and Maintenance of Neuronal Circuits in the Brain , 2007, Developmental Neuroscience.

[172]  Matthew J. Craig,et al.  Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. , 2007, Cancer research.

[173]  J. Julien,et al.  Increased glioma growth in mice depleted of macrophages. , 2007, Cancer research.

[174]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[175]  Helene Maccario,et al.  PTEN is destabilized by phosphorylation on Thr366. , 2007, The Biochemical journal.

[176]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[177]  M. Herlyn,et al.  Rewired ERK-JNK signaling pathways in melanoma. , 2007, Cancer Cell.

[178]  Xiuli Wang,et al.  Histone deacetylase inhibitor trichostatin a potentiates doxorubicin‐induced apoptosis by up‐regulating PTEN expression , 2007, Cancer.

[179]  K. Sabapathy,et al.  c-Jun promotes cellular survival by suppression of PTEN , 2007, Cell Death and Differentiation.

[180]  Cornelis J. Weijer,et al.  PtdIns(3,4,5)P3-Dependent and -Independent Roles for PTEN in the Control of Cell Migration , 2007, Current Biology.

[181]  P. Pandolfi,et al.  Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity , 2007, Cell.

[182]  Tom Misteli,et al.  Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression , 2007, Cell.

[183]  P. Pandolfi,et al.  NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN , 2007, Cell.

[184]  F. E. Bertrand,et al.  CBF-1 (RBP-Jk) Binds to the PTEN Promoter and Regulates PTEN Gene Expression , 2007, Cell cycle.

[185]  Taoyong Chen,et al.  Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8+ CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells , 2006, Journal of Molecular Medicine.

[186]  R. DePinho,et al.  PCAF Modulates PTEN Activity*♦ , 2006, Journal of Biological Chemistry.

[187]  M. Zöller,et al.  Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029. , 2006, Cancer research.

[188]  M. Gottesman,et al.  Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[189]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[190]  L. Cantley,et al.  Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.

[191]  S. M. Sims,et al.  Regulation of cancer cell migration and bone metastasis by RANKL , 2006, Nature.

[192]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[193]  Yoko Takahashi,et al.  PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling , 2006, The EMBO journal.

[194]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[195]  J. Massagué,et al.  TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. , 2005, Cancer cell.

[196]  Tomas Mustelin,et al.  Cooperative Phosphorylation of the Tumor Suppressor Phosphatase and Tensin Homologue (PTEN) by Casein Kinases and Glycogen Synthase Kinase 3β* , 2005, Journal of Biological Chemistry.

[197]  Taoyong Chen,et al.  More Efficient Induction of HLA-A*0201-Restricted and Carcinoembryonic Antigen (CEA)–Specific CTL Response by Immunization with Exosomes Prepared from Heat-Stressed CEA-Positive Tumor Cells , 2005, Clinical Cancer Research.

[198]  G. Adler,et al.  TGFβ-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN , 2005, Journal of Cell Science.

[199]  R. Weil,et al.  Breast cancer metastasis to the central nervous system. , 2005, The American journal of pathology.

[200]  Michael A. Gibson,et al.  Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells , 2005, Molecular Cancer Therapeutics.

[201]  J. Chin,et al.  Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis , 2005 .

[202]  Rong Zeng,et al.  Regulation of PTEN by Rho small GTPases , 2005, Nature Cell Biology.

[203]  G H Barnett,et al.  Pathobiology of brain metastases , 2005, Journal of Clinical Pathology.

[204]  W. Gerald,et al.  Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. , 2005, The Journal of clinical investigation.

[205]  J. Le Pecq,et al.  A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer , 2005, Journal of Translational Medicine.

[206]  F. Lozupone,et al.  Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. , 2004, Journal of the National Cancer Institute.

[207]  M. Cheeran,et al.  Role of Microglia in Central Nervous System Infections , 2004, Clinical Microbiology Reviews.

[208]  B. Rollins,et al.  CCL2 (monocyte chemoattractant protein-1) and cancer. , 2004, Seminars in cancer biology.

[209]  Ming Tan,et al.  PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. , 2004, Cancer cell.

[210]  B. Brew,et al.  Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification , 2004, Journal of leukocyte biology.

[211]  A. Hall,et al.  Regulation of Cell Migration by the C2 Domain of the Tumor Suppressor PTEN , 2004, Science.

[212]  Steffen Jung,et al.  Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.

[213]  R. Eils,et al.  From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[214]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[215]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[216]  Hong Wu,et al.  PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. , 2003, Cancer cell.

[217]  C. Eng,et al.  Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells. , 2003, Cancer research.

[218]  P. Steeg.  Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.

[219]  S. Park,et al.  PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. , 2002, Cancer research.

[220]  N. Restifo,et al.  Natural selection of tumor variants in the generation of “tumor escape” phenotypes , 2002, Nature Immunology.

[221]  William Arbuthnot Sir Lane,et al.  Direct identification of PTEN phosphorylation sites , 2002, FEBS letters.

[222]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[223]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[224]  Woojin Jeong,et al.  Reversible Inactivation of the Tumor Suppressor PTEN by H2O2 * , 2002, The Journal of Biological Chemistry.

[225]  E. Lam,et al.  Control of Cell Cycle Exit and Entry by Protein Kinase B-Regulated Forkhead Transcription Factors , 2002, Molecular and Cellular Biology.

[226]  T. Liu,et al.  Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region. , 2002, Biochemical and biophysical research communications.

[227]  J. Lammers,et al.  FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal , 2002, The Journal of cell biology.

[228]  C. Bucana,et al.  The seed and soil hypothesis: vascularisation and brain metastases. , 2002, The Lancet. Oncology.

[229]  J. Slingerland,et al.  PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest , 2002, Nature Medicine.

[230]  T. Mustelin,et al.  The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling , 2001, Nature Cell Biology.

[231]  T. Mak,et al.  Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease , 2001, Nature Genetics.

[232]  S. Emr,et al.  Ubiquitin-Dependent Sorting into the Multivesicular Body Pathway Requires the Function of a Conserved Endosomal Protein Sorting Complex, ESCRT-I , 2001, Cell.

[233]  R. Hennekam,et al.  Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes , 2001, The Lancet.

[234]  I. Pass,et al.  Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN , 2001, Current Biology.

[235]  Laurence Zitvogel,et al.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming , 2001, Nature Medicine.

[236]  M. Smyth,et al.  Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells , 2001, Nature Medicine.

[237]  Francisca Vazquez,et al.  Phosphorylation of the PTEN Tail Regulates Protein Stability and Function , 2000, Molecular and Cellular Biology.

[238]  T. Mak,et al.  High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. , 2000, Cancer research.

[239]  P. Hein,et al.  Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.

[240]  Tomohiko Maehama,et al.  Crystal Structure of the PTEN Tumor Suppressor Implications for Its Phosphoinositide Phosphatase Activity and Membrane Association , 1999, Cell.

[241]  Kenneth M. Yamada,et al.  Shc and Fak Differentially Regulate Cell Motility and Directionality Modulated by Pten , 1999, The Journal of cell biology.

[242]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[243]  C. Cordon-Cardo,et al.  Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[244]  T. Mak,et al.  High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice , 1998, Current Biology.

[245]  Laurence Zitvogel,et al.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes , 1998, Nature Medicine.

[246]  Anita B. Roberts,et al.  REGULATION OF IMMUNE RESPONSES BY TGF-β* , 1998 .

[247]  A. Roberts,et al.  Regulation of immune responses by TGF-beta. , 1998, Annual review of immunology.

[248]  Alan C. Evans,et al.  PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis , 1997, Journal of neuroscience research.

[249]  C. Eng,et al.  Germline mutations in PTEN are present in Bannayan-Zonana syndrome , 1997, Nature Genetics.

[250]  M. Ghiani,et al.  Tumor‐associated lympho‐monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines , 1997, International journal of cancer.

[251]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[252]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[253]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[254]  W. Hall,et al.  Brain metastases: Histology, multiplicity, surgery, and survival , 1996 .

[255]  H. Beug,et al.  TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. , 1996, Genes & development.

[256]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[257]  L. Deangelis,et al.  Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel , 1995, Cancer.

[258]  I. Fidler,et al.  Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. , 1995, Cancer research.

[259]  A. Kulkarni,et al.  Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. , 1995, Development.

[260]  I. Fidler,et al.  Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells , 1995, The Journal of experimental medicine.

[261]  W. Thomas,et al.  Cellular forms and functions of brain microglia , 1994, Brain Research Bulletin.

[262]  R. Derynck,et al.  TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors , 1994, The Journal of cell biology.

[263]  K. Alitalo,et al.  Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. , 1994, The Journal of biological chemistry.

[264]  K. McCarthy,et al.  Oligodendroglial lineage cells express neuroligand receptors , 1993, Glia.

[265]  C. Bucana,et al.  Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice. , 1992, The American journal of pathology.

[266]  R A Patchell,et al.  Brain metastases. , 1991, Neurologic clinics.

[267]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[268]  K. Frei,et al.  Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells , 1987 .

[269]  K. Frei,et al.  Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. , 1987, European journal of immunology.

[270]  M. Adam,et al.  Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes , 1985, The Journal of cell biology.

[271]  J. Tateishi,et al.  Transient expression of glial fibrillary acidic protein in developing oligodendrocytes in vitro. , 1985, Brain research.

[272]  P. Stahl,et al.  Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes , 1983, The Journal of cell biology.